İSKEMİK İNMESİ OLAN FABRY HASTASI: OLGU SUNUMU Fabry Patient With Ischemic Stroke: Case Report

Objective & Hypothesis:ÖZET Fabry hastalığı (FH), alfa galaktosidaz A (GLA) genindeki mutasyon nedeniyle oluşan, X’e bağlı kalıtılan lizozomal depo hastalığıdır.

📊

Key Findings & Data:Hastalığın atipik formunda klinik semptomlar daha geç yaşlarda ortaya çıkar ve en sık görülen tablolardan biri serebrovasküler hastalıklardır (SVH).

💡

Conclusion & Impact:Keywords: Fabry Disease, Cerebrovascular Disease, Young CVD

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:İSKEMİK İNMESİ OLAN FABRY HASTASI · OLGU SUNUMU · Fabry Patient With Ischemic Stroke

Özet

ÖZET Fabry hastalığı (FH), alfa galaktosidaz A (GLA) genindeki mutasyon nedeniyle oluşan, X’e bağlı kalıtılan lizozomal depo hastalığıdır. Hastalığın atipik formunda klinik semptomlar daha geç yaşlarda ortaya çıkar ve en sık görülen tablolardan biri serebrovasküler hastalıklardır (SVH). Özellikle genç erişkin SVH’ı olan hastalarda etyolojik neden olarak FH’nın akılda tutulması için bu vaka sunulmuştur. Anahtar Kelimeler: Fabry Hastalığı; Serebrovasküler Hastalık, Genç SVH ABSTRACT Fabry disease (FD) is an X-linked inherited lysosomal storage disease caused by mutations in the alpha galactosidase A (GLA) gene. In atypical form of the disease, clinical symptoms occur at a later age and one of the most common conditions is cerebrovascular disease (CVD). This case is presented to keep FD in mind as the etiological cause, especially in patients with young adult CVD. Keywords: Fabry Disease, Cerebrovascular Disease, Young CVD

Keywords

İSKEMİK İNMESİ OLAN FABRY HASTASI OLGU SUNUMU Fabry Patient With Ischemic Stroke

🔖

Cite This Article

GÜLTEKİN, M., SARILAR, A. Ç., BAYDEMİR, R., GÖL, M. F., YETKİN, M. F. (2020). İSKEMİK İNMESİ OLAN FABRY HASTASI: OLGU SUNUMU Fabry Patient With Ischemic Stroke: Case Report. Bozok Tıp Dergisi, Cilt: 10 - Sayı: 4, 119–122. https://ajindex.com/articles/478769

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (9)

Zarate YA, Hopkin RJ. Fabry's disease. The Lancet. 2008;372(9647):1427-35
Salviati A, Burlina AP, Borsini W. Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy. Neurological Sciences. 2010;31(3):299-306
Sims K, Politei J, Banikazemi M, Lee P. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke. 2009;40(3):788-94
Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195-203
Mehta A, Ginsberg L. Natural history of the cerebrovascular complications of Fabry disease. Acta paediatrica. 2005;94:24-7
Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. European journal of clinical investigation. 2004;34(3):236-42
Shi Q, Chen J, Pongmoragot J, Lanthier S, Saposnik G. Prevalence of Fabry disease in stroke patients—a systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases. 2014;23(5):985-92
Desnick R, Ioannou Y, Eng C. Fabry disease: a-galactosidase A deficiency. Metabolic and molecular bases of inherited disease New York: McGraw-Hill. 2001:3733-74
Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1996;40(1):8-17.